Novocure wins FDA nod for lung cancer treatment wearable
October 17, 2024
Novocure announced on Tuesday that the FDA treated its Optune Lua wearable device for treating metastatic non-small cell lung cancer.
Novocure announced on Tuesday that the FDA treated its Optune Lua wearable device for treating metastatic non-small cell lung cancer.
Johnson & Johnson MedTech (NYSE: JNJ)+
today announced the first completed commercial case with its Varipulse platform in Canada.
Mira has launched Mira Hormone Monitor: Menopause Transitions Kit to help women aged 35 and older track their hormones to spot early signs of perimenopause and manage them effectively.